A prospective, multicenter, real world study of Yangzheng Xiaoji capsule in the treatment of cancer-related fatigue
- Conditions
- Malignant solid tumor
- Registration Number
- ITMCTR2100004751
- Lead Sponsor
- Department of Radiotherapy, the Second Affiliated Hospital, Xi'an Jiaotong University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1.Patients diagnosed as malignant tumor (solid tumor) by pathology or cytology;
2.Patients with moderate to severe fatigue (4-10 points);
3.Clear mind, can objectively cooperate with the doctor to complete the examination and evaluation;
4.ECoG score of physical condition was 0-3;
5.Expected survival >= 3 months;
6.Aged 18-75 years;
7.Voluntary participation, signing informed consent, good compliance and cooperation with follow-up.
1.Patients with clinically significant liver dysfunction, i.e. glutamic oxaloacetic transaminase or alanine transaminase > 2.5 fold ULN, total serum bilirubin > 1.5 fold ULN;
2.Patients with clinically significant renal insufficiency, i.e. serum creatinine > 1.5 fold ULN;
3.Patients with severe heart disease, i.e. NYHA grade III-IV heart failure, unstable angina pectoris, myocardial infarction, underwent coronary artery reconstruction within 6 months before admission;
4.Patients with splenectomy or other serious hematopoietic system diseases;
5.Uncontrolled diabetes, hypertension (systolic blood pressure > 180mmhg and / or diastolic blood pressure > 120mmhg), uncontrollable infection, and severe peptic ulcer;
6.Mental patients without self-knowledge ability, those without legal capacity or limited legal capacity;
7.Patients who are pregnant, lactating or have the possibility of pregnancy and planned pregnancy;
8.Patients have participated in or are participating in other clinical studies in the past one month;
9.The researchers believe that there are any other unsuitable candidates. Determine other situations that may affect the clinical research and the interpretation of research results.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method